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Abstract 32 
We investigated the relationship between mitochondrial biogenesis, cell signalling and 33 
antioxidant enzymes by depleting skeletal muscle glutathione with diethyl maleate 34 
(DEM) which resulted in a demonstrable increase in oxidative stress during exercise. 35 
Animals were divided into six groups: (1) sedentary control rats; (2) sedentary rats 36 
treated with DEM; (3) exercise control rats euthanized immediately after exercise; (4) 37 
exercise rats + DEM; (5) exercise control rats euthanized 4 h after exercise; and (6) 38 
exercise rats + DEM euthanized 4 h after exercise. Exercising animals ran on the 39 
treadmill at a 10% gradient at 20 m/min for the first 30 min. The speed was then 40 
increased every 10 min by 1.6 m/min until exhaustion. There was a reduction in total 41 
glutathione in the skeletal muscle of DEM treated animals compared to the control 42 
animals (P<0.05). Within the control group, total glutathione was higher in the sedentary 43 
group compared to after exercise (P<0.05). DEM treatment also significantly increased 44 
oxidative stress, as measured by increased plasma F2-isoprostanes (P<0.05). Exercising 45 
animals given DEM showed a significantly greater increase in peroxisome proliferator 46 
activated receptor γ coactivator-1α (PGC-1α)  mRNA compared to the control animals 47 
that were exercised (P<0.05). This study provides novel evidence that by reducing the 48 
endogenous antioxidant glutathione in skeletal muscle and inducing oxidative stress 49 
through exercise, PGC-1α gene expression was augmented. These findings further 50 
highlight the important role of exercise induced oxidative stress in the regulation of 51 
mitochondrial biogenesis.  52 
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Introduction 54 
It is well documented that exhaustive exercise increases the production of reactive 55 
oxygen species (ROS) within skeletal muscle leading to oxidative stress (3, 4). It has 56 
been previously speculated that the increase in exercise-induced oxidative stress can 57 
reduce muscle performance (3). As such, antioxidants have been proposed to reduce 58 
exercise-induced oxidative stress and increase performance (41). Recently there have 59 
been a number of studies that suggests ROS are important cell signalling molecules, 60 
particularly for beneficial exercise-induced adaptations to skeletal muscle (9, 15). As a 61 
result, the use of antioxidant supplementation may result in a dampening of these positive 62 
adaptations initiated by ROS (10, 25). However, not all research supports this notion (12, 63 
35, 45).  64 
 65 
Mitochondrial biogenesis (synthesis) is one of the key processes involved in skeletal 66 
muscle adaptations to exercise. Peroxisome proliferator activated receptor γ coactivator-67 
1α (PGC-1α) is an important co-activator of this process and plays an intrinsic role in 68 
mitochondrial biogenesis (14, 27).  PGC-1α activates a broad range of both nuclear and 69 
mitochondrial encoded genes including nuclear respiratory factor-1 (NRF-1), NRF-2, and 70 
mitochondrial transcription factor A (Tfam). Specifically, PGC-1α regulates NRF-1 and 71 
NRF-2, which in turn regulate Tfam (17). Acute exercise stimulates PGC-1α gene 72 
expression, which increases mitochondrial synthesis and adaptations (1, 2, 11, 42). 73 
Furthermore, upstream signalling pathways such as phosphorylation of p38 mitogen-74 
activated protein kinase (p38 MAPK) and cAMP-response element binding protein 75 
(CREB) has been shown to activate PGC-1α (1, 16, 44).  76 
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  77 
A number of studies have attempted to elucidate mechanisms for the role of exercise-78 
induced ROS in cell signalling and mitochondrial biogenesis. Experimental approaches 79 
have included inhibiting ROS production, either by enzymatic inhibitors such as the 80 
treatment of allopurinol, or through antioxidant supplementation (9, 12, 18, 37, 38). Some 81 
studies suggest that long-term antioxidant supplementation attenuates markers of 82 
mitochondrial biogenesis following endurance training (10, 23, 31). By contrast, other 83 
studies report that short-term antioxidant supplementation does not influence changes in 84 
markers of mitochondrial biogenesis after acute exercise (11, 12, 26, 37). Alternatively, 85 
allopurinol, a xanthine oxidase inhibitor, has been shown to hamper PGC-1α expression 86 
after acute exercise (9, 18). However, Wadley et al. recently found that allopurinol did 87 
not alter PGC-1α expression after acute exercise and endurance training (38). These data 88 
highlight that the role of ROS in skeletal muscle adaptations is still largely unclear.  89 
 90 
We adopted an alternative approach to investigate the links between ROS, cell signalling 91 
and mitochondrial biogenesis following acute exercise. Specifically, we depleted skeletal 92 
muscle antioxidants using diethyl maleate (DEM) to increase oxidative stress during 93 
exercise, and measured the resultant changes in markers of mitochondrial biogenesis 94 
(PGC-1α and NRF-2), upstream signaling proteins (p38 MAPK and CREB) and 95 
endogenous antioxidants glutathione peroxidase (GPx-1) and superoxide dismutase 2 96 
(SOD2). We hypothesized that reducing intracellular glutathione would increase ROS 97 
production during acute exercise, resulting in an increase in markers of mitochondrial 98 
biogenesis, signaling proteins, and antioxidant enzymes.  99 
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Materials and Methods 100 
The University of Queensland Animal Ethics Committee approved this study in 101 
accordance with National Health and Medical Research Council guidelines.  102 
Animals 103 
Ten-week-old male Wistar rats (n=46) were purchased from the Central Animal Breeding 104 
House (The University of Queensland, Australia). They were housed two per cage for the 105 
duration of the study in a 12-hr light/dark cycle environment. Animals were fed on 106 
standard rat chow and tap water ad libitum.  107 
Experimental Protocol 108 
Animals were divided into six groups: (1) sedentary control rats (n=8); (2) sedentary rats 109 
treated with DEM (n=8); (3) exercise control rats euthanized immediately after exercise 110 
(n=8); (4) exercise rats + DEM (n=8); (5) exercise control rats euthanized 4 h after 111 
exercise (n=8); and (6) exercise rats + DEM euthanized 4 h after exercise (n=6). DEM 112 
rats were given an intraperitoneal injection of 3 mmol/kg body mass DEM dissolved in 113 
extra light olive oil and control animals were injected with the extra light olive oil 2 h 114 
prior to being sacrificed or exercised (8).  115 
 116 
Rats were exercised on a modified treadmill divided into eight lanes separated by clear 117 
plastic enclosures.  All animals were familiarised for 4 d to treadmill running prior to the 118 
start of the study, at a 10% gradient at 16-20 m/min for 30 min. Those rats that were 119 
willing to run were placed into the exercise groups. Previous research has shown that this 120 
selection process is considered appropriate, because health status and muscle physiology 121 
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properties do not differ between those rats willing to run or not (5). Approximately 72 h 122 
after familiarisation, the exercising rats ran on the treadmill at a 10% gradient at 20 123 
m/min for the first 30 min. The speed was then increased every 10 min by 1.6 m/min 124 
until exhaustion. Exhaustion was defined as the inability of the animal to right itself when 125 
it was laid on its side. The time until exhaustion was recorded for each animal (9, 18).  126 
Animals were weighed and sacrificed with sodium pentobarbital (100 mg/kg i.p.). Under 127 
a surgical plane of anaesthesia, blood was taken by cardiac puncture, and placed on ice. 128 
Samples were centrifuged at 600 × g for 10 min, and plasma aliquots were stored at -129 
80°C. Similar to previous studies depleting glutathione, red gastrocnemius skeletal 130 
muscle was excised, rapidly frozen in liquid nitrogen and stored at -80°C (32).  131 
Preparation of rat tissue 132 
Total RNA was extracted from frozen muscle by use of the Micro-to-Midi Total RNA 133 
Purification System kit and DNase on-column digestion (Invitrogen, Carlsbad, CA) as 134 
previously described (35). For immunoblotting and mitochondrial enzyme activity, 135 
frozen muscle (10:1 buffer/mg muscle) was homogenised as previously described (35, 136 
36) in freshly prepared ice-cold buffer (50 mM Tris at pH 7.5 containing 1 mM EDTA, 137 
10% vol/vol glycerol, 1% vol/vol Triton X-100, 50 mM NaF, 5 mM Na4P2O7, 1 mM 138 
DTT, 1 mM PMSF, and 5 μl/ml protease inhibitor cocktail (P8340; Sigma, St. Louis, 139 
MO)). Tissue lysates were incubated on ice for 20 min and then spun at 16,000 × g for 20 140 
min at 4°C. The activities of antioxidant enzymes were measured using frozen muscle 141 
samples, which had been homogenised, on ice in 0.1 M sodium phosphate buffer ph 7.0 142 
(10:1 buffer/mg muscle). Samples were spun at 16,000 × g for 15 min at 4ºC. The 143 
supernatant was transferred and analysis was done on freshly prepared homogenates. 144 
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Total and oxidized glutathione were analysed using frozen muscle tissue which was 145 
homogenized in 20 μl of 5% (wt/vol) 5-sulfosalicylic acid (SSA)/mg tissue and 146 
centrifuged at 11,500 rpm for 5 min at 4°C. The supernatant was diluted 1:5.5 in ddH2O. 147 
Triethanolamine was added to neutralise the solution to ensure optimal pH for the 148 
reaction. Separate aliquots of 100 μl were taken for total (tGSH) and oxidised (GSSG) 149 
glutathione measurement. The supernatant sample for the GSSG assay was derivatised in 150 
16 μl of the following solution: 30.8% triethanolamine, 0.4% SSA, and 9% 2-151 
vinylpyridine in ddH2O (7).  152 
Plasma F2-Isoprostanes 153 
As a marker of oxidative stress, F2-Isoprostanes were extracted from plasma GC/MS/MS 154 
(6). Isoprostanes were extracted from plasma after saponification with methanolic NaOH. 155 
Samples were spiked with 8-iso-PGF2α-d4 (Cayman Chemicals, USA) as an internal 156 
standard, and incubated at 42°C for 60 min. Samples were then acidified to pH 3 with 157 
hydrochloric acid; hexane was then added and the sample was mixed for 10 min before 158 
centrifugation at 3000 × g. The supernatant was removed and the remaining solution 159 
extracted with ethyl acetate and dried under nitrogen. Samples were reconstituted with 160 
acetonitrile, transferred into vials with glass inserts and dried. The samples were then 161 
derivatised using 40 µl of a 10% pentafluorobenzylbromide/acetonitrile solution (v/v) 162 
and 20 µl of a 10% diisopropylethylamine/acetonitrile solution (v/v), and incubated at 163 
room temperature for 30 min. Samples were then dried again under nitrogen before 10 µl 164 
of pyridine and 20 µl of a Bis(trimethylsilyl)trifluoroacetamide/Trimethylchlorosilane 165 
solution (99:1) (Sigma, St. Louis, MO) were added, and the samples were incubated at 166 
45° for 20 min. Finally, hexane was added and 1 μl of the sample was injected for 167 
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analysis using gas chromatography mass spectrometry (Varian, Australia) in negative 168 
chemical ionization mode. The laboratory intra-assay coefficient of variation for this 169 
assay is 4.5%. 170 
RT-PCR analysis 171 
RNA concentration was determined by spectrophotometric analysis. First-strand cDNA 172 
was generated from 0.5 μg RNA using AMV Reverse Transcriptase (Promega, Madison, 173 
WI) (39). Following reverse transcription, the remaining RNA was degraded by treatment 174 
with RNase H (Invitrogen, Australia) for 20 min at 37oC. The amount of single stranded 175 
DNA was then determined in each sample and compared against an oligonucleotide 176 
standard using OliGreen reagent (Invitrogen, Australia), which was incubated in the dark 177 
at 80oC for 5 min prior to the measurement of fluorescence (30, 35). The primer 178 
sequences were obtained from gene sequences from GenBank: PGC-1α, AY237127; 179 
NRF2α, M74515; SOD2, NM_017051.2 and GPx-1, NM_030826.3 (Table 1).  180 
 181 
Real-time PCR using SYBR Green chemistry was performed, using the sequence detector 182 
software (Rotor-Gene v6; Corbett Research, Sydney, Australia), as previously described 183 
(36). Samples were subjected to a heat dissociation protocol after the final cycle of PCR 184 
to ensure that only one product was detected. The mRNA of each gene was normalized to 185 
the cDNA content in each sample using the OliGreen assay as described above. This has 186 
previously been shown to be a robust and suitable method of normalization that avoids 187 
the many problems associated with “housekeeping genes” (22, 29, 30, 35). 188 
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Western Blot Analysis 189 
Lysates were solubilised in Laemmli sample buffer. Equal amounts of total protein,  190 
determined by a bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL) with BSA 191 
as the standard, were separated by SDS-PAGE and electrotransfer of proteins from the 192 
gel to PVDF membranes. Blots were probed with anti-p38 rabbit polyclonal MAPK (Cell 193 
Signalling, Hartsfordshire, England), and anti-phospho-CREB (Cell Signalling, 194 
Hartsfordshire, England) antibodies. Binding was detected with IRDye 800-conjugated 195 
anti-rabbit IgG (Rockland, Gilbertsville, PA) or IRDye 680-conjugated anti-mouse IgG 196 
(Invitrogen, Carlsbad, CA) secondary antibodies. All data are expressed as integrated 197 
intensity following infrared detection (Odyssey Imaging system; LI-COR Biosciences, 198 
Lincoln, NE). For p38 MAPK signalling, membranes were then stripped (2% SDS (w/v) 199 
in 25 mM glycine, pH 2.0) and re-probed with anti-phospho-p38 MAPK rabbit 200 
polyclonal antibody (Cell Signalling, Hartsfordshire, England). As a loading control, 201 
blots were then reprobed with anti-α-tubulin mouse monoclonal antibody (Sigma, St. 202 
Louis, MO).  203 
Glutathione and Antioxidant Enzyme Activities 204 
Total and GSSG glutathione concentrations were measured by modifying the method of 205 
Dudley (7). Absorbance was recorded on a plate reader (Fluostar Optima, BMG Labtech, 206 
Victoria, Australia). GPx activity was measured using a modified method for the Cobas 207 
Mira spectrophotometric analyser (Roche Diagnostics, Basel, Switzerland) (40). The 208 
method used to measure SOD2 activity was modified from Oyanagu (24). Protein 209 
concentration was determined using a BCA protein assay (Pierce, Rockford, IL) with 210 
BSA as the standard. 211 
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Statistical Analyses 212 
Data were checked for normality using the Shapiro-Wilk test. If the test was significant, 213 
data were log transformed and reanalyzed. Plasma F2-isoprostanes, and skeletal muscle 214 
tGSH, ratio of GSSG/tGSH, PGC-1α mRNA, NRF-2 mRNA, phosphorylated p38 MAPK 215 
protein, CREB protein, GPx mRNA, GPx activity, SOD2 mRNA and SOD2 activity were 216 
all normally distributed. Skeletal muscle GSSG was normally distributed after log 217 
transformation.   218 
 219 
An unpaired t-test was used to determine differences in time to fatigue between control 220 
exercise and DEM exercise groups. For all other data, a two-way ANOVA was used to 221 
determine an interaction between exercise and DEM treatment and if significant a 222 
Tukey’s post hoc was completed. If there was no interaction, where applicable, a main 223 
effect for exercise or DEM is provided. Animals sacrificed directly after exercise were 224 
used to determine plasma F2-isoprostanes, and skeletal muscle glutathione and cell 225 
signaling proteins (37). Markers of mitochondrial biogenesis and endogenous 226 
antioxidants were measured on animals euthanized 4 h after exercise (37). Significance 227 
was considered at P<0.05. Normalised data are presented as mean ± SE, and log 228 
transformed data as geometric mean ± 95% confidence intervals. 229 
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Results 230 
Effects of DEM and exercise on markers of skeletal muscle ROS directly after acute 231 
exercise 232 
Time to fatigue was significantly decreased as a result of DEM treatment (P<0.05; 68 ± 5 233 
mins exercise control (n=16) versus 51 ± 5 mins exercise DEM (n=14)).  234 
 235 
For tGSH levels, there was a significant interaction between DEM treatment and exercise 236 
(P<0.05; Figure 1A). In the control (untreated) rats, acute exercise significantly decreased 237 
skeletal muscle tGSH levels (P<0.05; Figure 1A). DEM treatment significantly reduced 238 
skeletal muscle tGSH levels compared to untreated rats (P<0.05, Figure 1A), with 239 
exhaustive exercise not reducing these levels any further (Fig 1A). In the control group, 240 
exercise resulted in a greater GSSG/tGSH ratio compared to the sedentary group 241 
(P<0.05), yet in the DEM treated animals, GSSG/tGSH ratio did not differ between the 242 
exercise and sedentary animals (P<0.05 interaction between exercise and DEM; Figure 243 
1C). There were no differences in GSSG between groups (P>0.05; Figure 1B). DEM 244 
treatment significantly increased oxidative stress, as measured by changes in plasma F2-245 
isoprostanes (P<0.05 main effect for DEM; Figure 2). 246 
Effect of DEM and exercise on mitochondrial biogenesis markers 4 h after acute 247 
exercise 248 
Four hours after exercise, PGC-1α gene expression was significantly increased in both 249 
control and DEM treated animals (P<0.05 interaction between exercise and DEM; Figure 250 
3A). Furthermore, exercising animals treated with DEM showed a significantly greater 251 
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increase in PGC-1α gene expression compared to the control animals that were exercised 252 
(P<0.05). Exercise did not significantly increase NRF-2 gene expression (P=0.1; Figure 253 
3B). 254 
 Effect of DEM and exercise on exercise-induced mitochondrial biogenesis signaling 255 
directly after exercise 256 
Phosphorylation of p38 MAPK was significantly increased after exercise in both the 257 
control and DEM treatment groups (P<0.05 main effect for exercise; Figure 4A). DEM 258 
tended to increase the phosphorylation of p38 MAPK (P=0.06; Fig 4A). Phosphorylated 259 
CREB was not altered as a result of exercise or DEM treatment (Figure 4B). 260 
Effect of DEM on endogenous antioxidants 4 h after acute exercise 261 
DEM treatment prevented the increase in GPx-1 mRNA observed in the control 262 
(untreated) group following acute exercise (P<0.05, Fig 5A). In animals treated with 263 
DEM, there was a significant reduction in GPx activity levels in the sedentary and 264 
exercise groups (P<0.05 main effect for DEM; Figure 5B).  265 
 266 
There was a trend for exercise to increase SOD2 gene expression (P=0.08; Figure 5C). 267 
SOD2 activity was reduced in the control exercise and DEM exercised animals (P<0.05 268 
main effect of exercise; Figure 5D). In addition, in the DEM groups SOD2 activity was 269 
reduced (P<0.05 main effect for DEM; Figure 5D).  270 
Discussion 271 
This study is the first to investigate the effects of depleting glutathione and thus 272 
increasing oxidative stress on skeletal muscle markers of mitochondrial biogenesis, 273 
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upstream signaling proteins and endogenous antioxidants following an acute exercise 274 
bout. Consistent with our hypothesis, DEM decreased tGSH and GSSG/tGSH. 275 
Furthermore, DEM treatment significantly increased oxidative stress during exhaustive 276 
exercise as measured by increased plasma isoprostanes. Our main finding was that DEM 277 
treatment significantly augmented PGC-1α mRNA following exhaustive exercise. In 278 
addition, both DEM and exhaustive exercise significantly lowered GPx-1 gene 279 
expression. DEM also lowered total GPx-1 and SOD2 activity in both sedentary and 280 
exercise groups. DEM treatment also tended to augment the increased phosphorylation of 281 
p38 MAPK following exhaustive exercise.   282 
 283 
DEM treatment decreased skeletal muscle tGSH by approximately 52% which has been 284 
previously demonstrated  in similar exercise studies using L-butathione-(S,R)-sulfoximine 285 
(BSO), which also reduces glutathione biosynthesis (20, 32). The decrease in skeletal 286 
muscle tGSH post-exercise in the control group suggests that exercise alone depleted 287 
skeletal muscle glutathione, and is the result of tGSH responding to the oxidative 288 
challenge induced by exercise (21). Consistent with previous rodent treadmill studies, 289 
skeletal muscle GSSG/tGSH ratio was significantly increased in the control animals post-290 
exercise, which is indicative of oxidative stress (37, 38). Wadley et al. have previously 291 
found that GSSG/tGSH as an indirect marker of ROS production during exercise is more 292 
sensitive than other ROS measures, such as protein carbonyls and H2O2 levels (37). 293 
However, in this instance these markers are not appropriate to determine the increase in 294 
ROS in DEM-treated animals, because DEM reduced both tGSH and GSSG/tGSH. 295 
Accordingly, we measured plasma F2-isoprostane concentration as an alternative marker 296 
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of oxidative stress, which confirmed the expected increase in ROS production within the 297 
DEM groups.                                                                                                                                                        298 
 299 
A major finding of this study was that DEM treatment diminished the glutathione pool, 300 
resulting in inability of skeletal muscle to limit   oxidative stress, and therefore 301 
augmented PGC-1α gene expression following exhaustive exercise. Recent in vitro 302 
evidence suggests that increases in PGC-1α promoter activity and gene expression are 303 
mitigated by increased hydrogen peroxide levels in skeletal muscle (15, 33, 34). Given 304 
that one of the major roles of glutathione system is to reduce hydrogen peroxide to water, 305 
and we diminished the glutathione pool, it is possible this resulted in an increase in 306 
hydrogen peroxide, thus a potential pathway for the changes seen in PGC-1α gene 307 
expression. Although there was a trend for exercise to increase NRF-2 gene expression, 308 
DEM treatment did not affect this gene. It is possible that NRF-2 gene expression is not 309 
sensitive to increases in ROS following treatment with DEM.  310 
 311 
The signaling proteins, p38 and CREB, are involved in the regulation of PGC-1α gene 312 
expression (1, 43). Consistent with our previous studies, acute exercise significantly 313 
increased p38 MAPK phosphorylation (37, 38). Indeed, an increase in phosphorylation of 314 
p38 MAPK, followed by the exercise-induced increase in PGC-1α gene expression is also 315 
similar to that reported by Akimoto et al., providing further support of the functional role 316 
of p38 in skeletal muscle adaptations (1). Skeletal muscle phosphorylation of p38 MAPK 317 
also tended (P=0.06) to be higher with DEM-treatment. It appears that oxidative stress 318 
resulting from DEM treatment may have increased p38 MAPK activation. Indeed, this is 319 
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supported by previous evidence which has demonstrated acute exercise increased 320 
phosphorylated p38 (37, 38).  Alternatively, it does not appear that CREB is activated by 321 
oxidative stress, which did not change significantly.   322 
 323 
In vitro evidence suggests that PGC-1α is a powerful inducer of antioxidants GPx and 324 
SOD2. When PGC-1α is gene silenced, there are concurrent decreases in the gene 325 
expression of these antioxidants (34). Indeed, as exercise increased PGC-1α gene 326 
expression in the controls animals within this study, similar increases were also seen in 327 
GPx-1 and a tendency for reduced SOD2 gene expression. These increases have been 328 
previously reported in skeletal muscle after acute exercise (37). DEM-treatment 329 
decreased both GPx-1 gene expression and GPx activity. Most likely this is the result of 330 
the significant reduction in tGSH in the DEM animals. Although we did not expect to see 331 
any changes in GPx activity following acute exercise, this measure was used to 332 
demonstrate how DEM influences different components of the glutathione system. In the 333 
control group, SOD2 activity was reduced after exercise. Several studies have reported no 334 
alteration in SOD2 activity after acute exercise (13, 28). Nevertheless, it remains unclear 335 
why exercise does not alter SOD2 activity. In addition, DEM decreased SOD2 activity in 336 
both the sedentary and exercise groups. We speculate that this overall decrease indicates 337 
that SOD2 activity is dependent on glutathione status at rest compared to exercise.   338 
 339 
DEM significantly decreased time to fatigue by 25%, confirming the findings of others 340 
that reported impaired skeletal muscle function with oxidative stress (19, 32). Both DEM 341 
and BSO treatment have previously resulted in reductions in swimming distance (19) and 342 
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time to fatigue (32), respectively. One limitation of the present study was the exercise to 343 
exhaustion protocol, where the reduced time to fatigue in the exercise DEM group would 344 
have resulted in reduced energy expenditure compared to the exercise controls, and 345 
therefore the possibility of reduced exercise-induced adaptations. Nevertheless, 346 
irrespective of the energy expenditure and shorter running time, PGC-1α gene expression 347 
following exercise was actually higher in the DEM group. In addition we also chose to 348 
use the DEM as a glutathione inhibitor, however, we suspect similar results would still be 349 
yielded using the alternative glutathione inhibitor BSO or the SOD inhibitor, 350 
diethyldithiocarbamate. Further studies could explore these alternative inhibitors to 351 
confirm findings reported here.  352 
 353 
This study has demonstrated novel evidence that by reducing endogenous antioxidant 354 
glutathione content, there was impaired capacity for skeletal muscle to neutralize 355 
oxidative stress during exercise, resulting in greater PGC-1α gene expression. Therefore, 356 
providing in vivo evidence for the important role of oxidative stress plays in the 357 
regulation of mitochondrial biogenesis. 358 
  359 
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Table 1: Primers for mRNA analyses 510 
Gene  Forward Primer (5ʹ-3ʹ) Reverse Primer (5ʹ-3ʹ) 
PGC-1α  ACCCACAGGATCAGAACAAACC GACAAATGCTCTTTGCTTTATTC
NRF2α CTCGGAGCAGGTGACGAG TGGACCAGCGTATAGGATCA 
SOD2 TGGACAAACCTGAGCCCTAA GACCCAAAGTCACGCTTGATA 
GPx-1 CGACATCGAACCCGATATAGA ATGCCTTAGGGGTTGCTAGG 
 511 
  512 
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Figure 1: Effects of DEM and exercise on levels of total glutathione (tGSH) (A), oxidised 513 
glutathione (GSSG) (B) and the GSSG/tGSH ratio (C). Animals in the post-exercise 514 
groups were sacrificed directly after exercise. Values are mean ± SE for tGSH, 515 
GSSG/tGSH ratio and geometric mean (95% CI) for GSSG (n=5-8 for all groups).   516 
‡ P<0.05 interaction between exercise and DEM. 517 
 518 
Figure 2: Effects of DEM and exercise on concentration of plasma F2-isoprostanes. 519 
Animals in the post-exercise groups were sacrificed directly after exercise. Values are 520 
mean ± SE (n=6-8 for all groups). +P<0.05 main effect for DEM. 521 
  522 
Figure 3: Effects of DEM and exercise on PGC-1α (A) and NRF-2 (B) gene expression. 523 
Animals in the exercise-recovery groups were sacrificed 4 h after exercise. Values are 524 
mean ± SE (n=6-8 for all). ‡ P<0.05 interaction between exercise and DEM 525 
 526 
Figure 4: Effects of DEM and exercise on protein content of phosphorylated p38 (A) and 527 
phosphorylated CREB (B). Animals in the post-exercise groups were sacrificed directly 528 
after exercise. Values are mean ± SE (n=8 for all groups). Boxes: Western blot showing 529 
representative results from 1 rat/group with boxes around blots indicating blots were 530 
obtained from different parts of the same membrane. *P<0.05 main effect for exercise.  531 
 532 
Figure 5: Effects of DEM and exercise on changes in gene expression and enzyme 533 
activity of GPx-1 (A and B) and SOD2 (C and D). Animals in the exercise-recovery 534 
groups were sacrificed 4 h after exercise. Values are mean ± SE (n=6-8 for all groups). ‡ 535 
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P<0.05 interaction between exercise and DEM; *P<0.05 main effect for exercise; 536 
+P<0.05 main effect for DEM. 537 
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